Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Balykova

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 3, 2003
[Effect of mexidol on efficacy of traditional therapy of sick sinus syndrome in adolescents]L A Balykova
Kardiologiia|March 4, 2009
[Information communication about Joint 9-th Congress of Russian Society for Holter Monitoring and Noninvasive Electrophysiology and 2-nd Russian Congress "Clinical Electrocardiology"]L M Markov, V N Komoliatova, S N Chuprova, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|December 22, 1999
[Study of various mechanisms of anti-arrhythmia activity of phosphoenol pyruvate]V P Balashov, E A Sosunov, L A Balykova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1996
[The anti-arrhythmia activity of energy-providing and electron-acceptor compounds]V P Balashov, L A Balykova, Ia V Kostin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|July 12, 2002
[Effect of mexidol, emoxypine, and dimephosphon on electrophysiological effects of nibentan]A A Kotliarov, N V Kurkina, L E Smirnova, et al.
Kardiologiia|October 27, 2012
[Changes of QT interval during graded exercise test in healthy adolescents aged 11-15 years]L M Makarov, L A Balykova, I A Gorbunova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 28, 2008
[The efficacy of the ultrashort-term action insulin-lispro preparation "humalog" and the antioxidant mexidol in the complex treatment of type I diabetes in infants and adolescents]E N Masiagina, L A Balykova, L Iu Mukhina, et al.
Kardiologiia|July 27, 2021
[Cardiovascular Risks Associated with the use of Performance-Enhancing Stimulants]L A Balykova, L M Makarov, S A Ivyanskiy, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|April 6, 1999
[Effects of biotechnological cytochrome c on early postocclusion and reperfusion arrhythmias]L A Balykova, V P Balashov, Ia V Kostin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|April 15, 2004
[Anti-arrhythmia activity of derinat in an experiment]O I Sviatkina, V P Balashov, L A Balykova, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Eksperimental'Naia I Klinicheskaia Farmakologiia|December 3, 2003
[Effect of mexidol on efficacy of traditional therapy of sick sinus syndrome in adolescents]L A Balykova
Kardiologiia|March 4, 2009
[Information communication about Joint 9-th Congress of Russian Society for Holter Monitoring and Noninvasive Electrophysiology and 2-nd Russian Congress "Clinical Electrocardiology"]L M Markov, V N Komoliatova, S N Chuprova, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|December 22, 1999
[Study of various mechanisms of anti-arrhythmia activity of phosphoenol pyruvate]V P Balashov, E A Sosunov, L A Balykova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 1, 1996
[The anti-arrhythmia activity of energy-providing and electron-acceptor compounds]V P Balashov, L A Balykova, Ia V Kostin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|July 12, 2002
[Effect of mexidol, emoxypine, and dimephosphon on electrophysiological effects of nibentan]A A Kotliarov, N V Kurkina, L E Smirnova, et al.
Kardiologiia|October 27, 2012
[Changes of QT interval during graded exercise test in healthy adolescents aged 11-15 years]L M Makarov, L A Balykova, I A Gorbunova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|March 28, 2008
[The efficacy of the ultrashort-term action insulin-lispro preparation "humalog" and the antioxidant mexidol in the complex treatment of type I diabetes in infants and adolescents]E N Masiagina, L A Balykova, L Iu Mukhina, et al.
Kardiologiia|July 27, 2021
[Cardiovascular Risks Associated with the use of Performance-Enhancing Stimulants]L A Balykova, L M Makarov, S A Ivyanskiy, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|April 6, 1999
[Effects of biotechnological cytochrome c on early postocclusion and reperfusion arrhythmias]L A Balykova, V P Balashov, Ia V Kostin, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|April 15, 2004
[Anti-arrhythmia activity of derinat in an experiment]O I Sviatkina, V P Balashov, L A Balykova, et al.
Pageof 2